Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Kidney Diseases

• Treatment of Patients With Diabetic Kidney Disease
• Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
• Canagliflozin in Advanced Renal Disease With MRI Endpoints
• Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis
• SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
• Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
• Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
• Ameliorating Contrast Induced Nephropathy After Coronary Angiography
• A Trial of HRS-5965 Tablets in Primary IgA Nephropathy
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
• Acute Equol Supplementation and Vascular Function in Women With and Without CKD
• Drug Nephrotoxicity Amelioration by N-acetylcysteine
• REmission in Membranous Nephropathy International Trial (REMIT)
• The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy
• Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients
• Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC
• Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
• Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
• Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
• Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
• The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
• Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation
• GLUcose Transport and REnalPROtection in Chronic Kidney Disease
• A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
• Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
• A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
• A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants
• A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
• CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
• Bone in CKD Alkali Response (BICARb Pilot Trial)
• A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
• Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients
• Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - A Pilot Study
• Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
• A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Ch
• Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
• A Clinical Study of MIL62 in Primary Membranous Nephropathy
• A Study of BION-1301 in Adults With IgA Nephropathy
• Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
• Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy
• Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease
• Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
• Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD)
• PTH Attenuation Trial in Hemodialysis-2
• Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
• A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy
• Randomized Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
• The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
• A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants
• A Study of Telitacicept in Patients With Primary IgA Nephropathy
• A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
• Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease
• Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy
• Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution
• Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring
• Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)
• A Study of Renal Microvessel Imaging for Chronic Kidney Disease
• A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients
• Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease
• NAD Augmentation in Diabetes Kidney Disease
• Perioperative Nitric Oxide Prevents Acute Kidney Injury in Cardiac Surgery Patients With Chronic Kidney Disease
• Azilsartan in Patients With Diabetic Kidney Disease and Hypertension
• Gabapentin Versus Loratadine in Uremic Pruritus
• A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients
• ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
• Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
• The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
• Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients
• Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
• An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases.
• Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
• Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
• Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria
• meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
• Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children
• Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study.
• A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
• A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy
• Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
• A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
• A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
• Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
• Denosumab Treatment in CKD Patients at High Risk of Fracture
• Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia
• A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
• DApagliflozin Cardiovascular Effects on Patients at End-stage REnal Disease
• Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
• Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
• A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
• A Study of MK-2060 in Participants With Chronic Kidney Disease (MK-2060-011)
• Safety, Feasibility, and Tolerability of Sulforaphane in Children With Chronic Kidney Disease
• Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease
• Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects
• ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
• Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
• A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
• Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
• Effect of Allopurinol on Markers of Mineral and Bone Metabolism
• Phase III Study of Telitacicept in Patients With IgA Nephropathy
• Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
• Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients
• A Study to Assess the Effects of Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
• A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
• A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation
• Oral Iron Supplementation for Patients With Chronic Kidney Disease
• Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
• Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
• A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease
• A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal
• A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).
• Phase 2, Efficacy, Safety, and Pharmacokinetics Study of Two INV-202 Doses in Patients With Diabetic Kidney Disease
• Rituximab or Cyclophosphamide Combined With Steroids in Idiopathic Membranous Nephropathy
• Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
• Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
• Renal Mechanism of SGLT2 Inhibition
• A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single a
• Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
• Investigational and Comparative Study in the Management of Diabetic Nephropathy
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
• The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial
• Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney
• A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
• Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
• A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
• CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
• Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy
• One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
• Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of US-APR2020 In Subjects With CKD IV Completing The US-APR2020-01 Study
• Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropaties: a Cross-over Randomized Clinical Trial
• A Clinical Study of MIL62 in Primary Membranous Nephropathy
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
• Evaluate the Effect and Safety of Pu Yang Wan Wu Tang and Western Medicine on Chronic Kidney Disease
• A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation
• The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
• Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
• HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
• Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
• Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
• Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
• Targeting Leukotrienes in Kidney Disease
• Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients With Chronic Kidney Disease
• CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus and Not on Dialysis
• The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
• Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
• Novel Desensitization Protocol for Highly Sensitized Patients to Allow for Successful Kidney Transplantation. A Pilot Study.
• A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus and Not on Dialysis
• MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)
• Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
• A Phase 1 Dose Escalation Study to Evaluate Safety and Pharmacokinetics (PK) of VX-840 in Healthy Participants
• Phase 2/3 Adaptive Study of VX-147 in Adults With APOL1- Mediated Proteinuric Kidney Disease
• Empagliflozin in Acute Heart Failure
• Double-blind Randomized Controlled Trial Investigating the Effects of Calcitriol on Biomarkers in Diabetic Kidney Disease Patients
• A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects
• An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients
• A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
• Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease
• Enhancing the Natriuretic Peptide System in HFpEF
• A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
• Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
• Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
• A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes
• Testosterone Treatment in Men With Chronic Kidney Disease
• Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
• Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
• Sleep Disorders in Chronic Kidney Disease Patients
• Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
• Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis
• Basal Plus GLP1-ra on Glycemic Variability in CKD
• A Study to Test BI 764198 in People With a Type of Kidney Disease Called Primary Focal Segmental Glomerulosclerosis
• Open-label, Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303
• Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease
• A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Childr
• PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
• A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
• DIalysis Symptom COntrol-Pruritus Outcome Trial
• SGLT2 Inhibition in Hemodialysis
• A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
• Drug Eluting Balloon (DEB) vs Plain Old Balloon Angioplasty (POBA) in the Treatment of Failing Dialysis Access
• Sit Less, Interact and Move More (SLIMM) 2 Study
• Diuretics and Volume Overload in Early CKD
• BCX9930 for the Treatment of C3G, IgAN, and PMN (RENEW)
• Study of Sulphoraphane in Chronic Kidney Disease
• The Effects of TMZ on Diabetic Nephropathy
• Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
• A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients With Chronic Kidney Disease-Associated Pruritus
• Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)
• Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)
• The Danish Pre-HCQ COVID Dialysis Study
• Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
• Study of ALXN2050 in Proliferative Lupus Nephritis (LN) and Immunoglobulin A Nephropathy (IgAN)
• PRevEnting FracturEs in Renal Disease - 1
• A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function
• Study for Desensitization of Chronic Kidney Disease Adult Patients in Need of a Kidney Transplant Who Are Highly Sensitized to Human Leukocyte Antigen
• Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents
• Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease
• To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Severe Pruritus
• Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy
• To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.
• MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
• Multidiscipline Care for Acute Kidney Disease (AKD)
• Obinutuzumab in Primary MN
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
• the Accuracy and Safety of Renal Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
• A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
• Effect of Dietary Magnesium Supplementation vs. Dapagliflozin in Patients With Diabetic Kidney Disease (DKD)
• Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (Factor XI Hemodialysis Study) (MK-2060-007)
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
• Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
• STUDY OF RENAL AUTOLOGOUS CELL THERAPY (REACT) IN SUBJECTS WITH TYPE 1 or 2 DIABETES AND CHRONIC KIDNEY DISEASE (REGEN-007)
• A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.
• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Parti
• Lokelma for RAAS Maximisation in CKD & Heart Failure.
• A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism
• Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants
• A Phase 1/2 Study Evaluating the Safety and Efficacy of CLBS201 in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
• Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
• Randomized Trial of Veverimer on Muscle Mitochondrial Energetics and Physical Endurance in Persons With CKD
• Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial
• Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD
• Comparison of Serum Calcium Level Between Preoperative Vitamin D and Non-vitamin D Regimen of Total Parathyroidectomy in End-stage Renal Failure Patients in Rajavithi Hospital
• Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease
• Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease
• An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
• Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
• A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers
• HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
• Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
• Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction
• Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus
• N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease
• Clinical Trial To Evaluate Safety And Efficacy Of US-APR2020 In Subjects With Chronic Kidney Disease Stage IV
• Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease
• To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers and Autosomal Dominant Polycystic Kidney Disease Subjects
• A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution
• A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy
• A Phase 1 Study of SSS17 in Healthy Subjects.
• Rescue Therapy With the Human Anti-CD38 Antibody MOR202 (Felzartamab) in Patients With Membranous Nephropathy Who Failed Anti-CD20 Target Therapy
• Curcuminoids and Contrast-induced Acute Kidney Injury
• A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease
• SER150 vs Placebo in Diabetic Kidney Disease
• First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes
• Stem Cell Therapy for Chronic Kidney Disease
• A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
• Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
• Comparing Sevoflurane With Propofol Sedation in ESRF Patients
• Steroids Therapy in IgA Nephropathy With Crescents
• Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment
• Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function
• Dapagliflozin in Non-diabetic Stage IV CKD
• A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
• A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
• Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine
• Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease
• Possible Role of Roflumilast in Diabetic Nephropathy
• A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
• Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
• Different Immunosuppressive Treatment in iMN
• Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
• Ferric Citrate and Chronic Kidney Disease in Children
• Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
• A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Chronic Kidney Disease Who do Not Have Diabetes
• Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers
• Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
• Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)
• Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
• Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
• Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis
• Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
• Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
• Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Subjects With Chronic Kidney Disease (CKD), Stages 3 and 4
• Gemigliptin and Biomarkers of Kidney Injury and Vascular Calcification
• Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat
• A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)
• Plazomicin Study in ESRD Patients Receiving IHD
• Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.
• Berinert (C1INH) vs Placebo for DGF/IRI
• Open-Label Extension Study of BION-1301 in IgA Nephropathy
• Desidustat in the Treatment of Chemotherapy Induced Anemia
• Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
• A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
• Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
• A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.
• Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia
• A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg
• Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
• Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
• A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
• Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
• Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease
• Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis
• Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
• Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access
• Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD
• Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease
• Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
• A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Atrasentan in Patients With Proteinuric Glomerular Diseases
• Atrasentan in Patients With IgA Nephropathy
• Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
• Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy
• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
• A Pharmacokinetic Study of Sugammadex in Dialysis Patients
• Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease
• A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol
• Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia
• PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD
• Efficacy of Diuretics in Kidney Disease
• Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)
• A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease
• Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy
• Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Abso
• Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers
• Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
• Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy
• Rituximab and RASi in Patients With IgAN
• Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
• Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
• A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
• QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
• Evolocumab In Advanced Chronic Kidney Disease Trial
• Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressur
• Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
• The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial
• A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
• Iron Therapy in Patients With End-Stage Renal Disease
• Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.
• A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
• Combination of Novel Therapies for CKD Comorbid Depression
• Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease
• Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
• A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease
• African American Study of Kidney Disease and Hypertension
• The Modification of Diet in Renal Disease Study
• Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
• A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
• A Study of SSS17 in Healthy Subjects
• Niclosamide Role in Diabetic Nephropathy
• Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
• Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
• Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation
• Safety and Efficacy Study of VIS649 for IgA Nephropathy
• Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
• Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease
• A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart
• The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial
• REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations
• Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
• Renohemodynamic Effects of Combined empagliflOzin and LosARtan
• The Use of Midazolam and Remifentanil During Dialysis Access Procedures
• Role of Fexofenadine in Diabetic Kidney Disease
• Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD
• Desidustat in the Treatment of Anemia in CKD on Dialysis Patients
• Food Effect Study of DDO-3055 Tablets in Healthy Subjects
• Diuretics and Volume Overload in Early CKD
• A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body
• A Phase 2b Diabetic Kidney Disease Study
• A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
• A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient
• Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
• Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
• SGLT2 Inhibitors in Glomerular Hyperfiltration
• Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
• Curcumin and Exercise in Chronic Kidney Disease
• Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS
• Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes
• Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics
• Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy
• Multiple Doses of DM199 in Patients With Chronic Kidney Disease
• ESP Block for Laparoscopic Nephrectomy Surgeries
• Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy
• A Study With SnPP, in Healthy Volunteers and Subjects With Stage 3-4 Chronic Kidney Disease
• A Study With Iron Sucrose in Healthy Volunteers and Chronic Kidney Disease Stage 3-4 Subjects
• Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.
• A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
• Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
• Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Subjects With Chronic Kidney Disease
• Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease
• Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy
• Long Term Extension Study in Patients With Primary Hyperoxaluria
• Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
• Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.
• A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
• Study Evaluating the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease
• A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed Condition
• A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy
• Desidustat in the Treatment of Anemia in CKD
• Apixaban in Subjects With Peritoneal Dialysis
• Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease
• Oral Iron in Children With Chronic Kidney Disease
• A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia
• A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
• L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
• A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease
• Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
• Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis
• The Effect of Etelcalcetide on CKD-MBD
• Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
• Belimumab With Rituximab for Primary Membranous Nephropathy
• Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects
• Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
• HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis
• Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)
• Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial
• Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
• Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD
• Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis
• Uric Acid Lowering Trial in Youth Onset T2D
• Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.
• A Study With RBT-1, in Healthy Volunteers and Subjects With Stage 3-4 Chronic Kidney Disease
• Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
• Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)
• Effects of Fenofibrate Therapy in Diabetic Nephropathy
• Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.
• Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
• Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2
• Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients
• A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
• A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects
• Metformin as RenoProtector of Progressive Kidney Disease
• Better Evidence for Selecting Transplant Fluids
• Magnesium Supplementation in Diabetic Nephropathy
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
• Mechanisms of EPO-induced Hypertension
• Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy
• Personalized Medicine for Membranous Nephropathy
• Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
• Aspirin to Target Arterial Events in Chronic Kidney Disease
• Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
• RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
• Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease
• End-stage Renal Disease (ESRD) Pilot Study
• Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
• Renoprotective Effects of Telbivudine in Chronic Hepatitis B
• Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
• Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease（CKD）Patients With Heart Failure
• Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)
• Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease
• A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
• A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease
• Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?
• Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease
• Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).
• Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
• Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)
• Chronic Kidney Disease (CKD) Platelet Study
• PA21 Safety and Efficacy in Adult Chinese Subjects
• Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
• Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
• RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine
• Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
• Study of Etelcalceide in Pediatric Subjects With Secondary Hyperparathyroidism and CKD on Hemodialysis
• Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
• Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
• The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
• Pentoxifylline in Diabetic Kidney Disease
• Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
• Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy
• Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
• Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
• A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
• Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
• The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD
• Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern
• Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
• Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease
• The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
• Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney D
• Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease
• Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation
• Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease
• Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
• Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
• Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
• HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
• The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
• A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study
• Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)
• Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population
• Tolvaptan-Octreotide LAR Combination in ADPKD
• Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
• A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients
• To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)
• Safety and Efficacy of Two Year Spnol and Maximal R Blockad Therapy
• Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease
• The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
• Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
• Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients
• Effect of Immunosuppression in IgA Nephropathy
• The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
• Blood Pressure Lowering in Dialysis (BOLD) Trial
• Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study
• Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
• Different Effects of Non-calcium Phosphate Binders on Serum Calcium
• Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
• Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
• Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
• Effect of Hyperuricaemia on Chronic Renal Disease
• Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
• Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD
• A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
• Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients
• Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
• Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
• Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
• Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation
• A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
• Removal of Beta Blocker Drugs by Hemodialysis
• A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis
• TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
• Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
• Study of FFI-1010 in Pediatric Kidney Disease
• Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
• The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia
• Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease
• Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
• Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
• Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
• Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
• Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)
• Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
• A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension
• Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
• Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
• Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
• A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
• KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
• A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
• Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease
• A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria
• Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
• Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial
• Ixazomib for Desensitization
• Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy
• Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD
• Hyperphosphatemia in Children With Chronic Kidney Disease
• Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
• Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension
• Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
• A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
• Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria
• Treatment of IgA Nephropathy According to Renal Lesions
• Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
• Mitochondria and Chronic Kidney Disease
• Empaglifozin in Early Diabetic Kidney Disease
• A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein
• Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy
• This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated
• This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)
• Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease
• High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Nephrectomy
• A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis
• Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
• Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan
• A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir
• Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease
• Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents
• Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)
• A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001
• Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
• A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease
• Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
• Toradol to Reduce Ureteroscopic Symptoms Trial
• Biokinetics Study for Tc-99m MAG3 in Pediatric Molecular Imaging
• Biokinetics Study of Tc-99m DMSA in Pediatric Molecular Imaging
• IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease
• Renal Anhydramnios Fetal Therapy
• A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
• Empagliflozin and Renal Oxygenation in Healthy Volunteers
• Savolitinib vs. Sunitinib in MET-driven PRCC.
• Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
• The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
• EMPRA (EMPagliflozin and RAs in Kidney Disease)
• Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients
• Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease
• Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
• Sargramostim for Myeloid Dendritic Cell Deficiency
• Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
• Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
• Ferric Citrate in ESRD Pilot Project
• Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
• Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105
• Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease
• Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease
• A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
• Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
• Adrenocorticotropic Hormone in Membranous Nephropathy
• Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
• Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease
• Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer
• The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage
• Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy
• Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
• Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
• Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
• A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
• Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
• A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
• Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
• Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
• A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
• A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
• Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes
• Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
• Ferumoxytol for Magnetic Resonance Imaging in Patients With Severe Kidney Disease
• A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
• Neurovascular Transduction During Exercise in Chronic Kidney Disease
• Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C
• Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
• Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
• Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease
• Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
• Bicarbonate Administration in CKD
• Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes
• Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis
• Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes
• Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
• Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
• Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease
• The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
• Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
• DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
• Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT)
• Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
• Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
• Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver
• Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
• Senescence in Chronic Kidney Disease
• A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma
• Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease
• A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis
• Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
• Microalbuminuria and Allopurinol in Type 1 Diabetes
• Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients
• CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
• Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
• Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis
• Efficacy and Safety of Atacicept in IgA Nephropathy
• Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes
• HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)
• Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)
• Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease
• Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis
• Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
• Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
• Periodic Versus Continuous IV Iron Supplementation in HD Patients
• A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia
• A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia
• A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment
• Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?
• Propolis Effects in Patients With Chronic Kidney Disease
• Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
• A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia
• Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
• Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
• A Trial of Doxycycline in Renal Disease
• Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
• Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
• Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease
• A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN).
• Efficacy of Tolvaptan on ADPKD Patients
• Remission Clinic in Proteinuric Chronic Nephropathies
• Integrative Medicine of IgA Nephropathy
• May Metformin be Used in Renal Failure?
• Effects of Dexmedetomidine on Microcirculation of Kidney Transplant Recipient
• Resveratrol's Effects in Diabetic Nephropathy
• Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
• Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
• Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-sti
• Contrast-enhanced Ultrasound of the Kidney
• Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
• Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
• An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy
• An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
• Apixaban in Hemodialysis
• Determining Oral Phosphate Tolerance Across the Spectrum of Glomerular Filtration Rate
• Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus
• Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy
• Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
• FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis
• FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease
• Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial
• Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
• Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
• Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
• A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
• Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy
• A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
• Comparison of Effectiveness and Safety of Three Lock Solutions for Long-Term Central Venous Catheter for Hemodialysis
• A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101
• Study on the Therapeutic Effect of TCM Treatment for MDR MN
• Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
• A Study of LY3113593 in Participants With Chronic Kidney Disease
• Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults
• Severe Sepsis in Children - IMPRESS-C
• Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis
• Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients
• A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
• Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
• CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
• COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
• Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
• The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
• Rituximab in Recurrent IgA Nephropathy
• A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis
• Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial
• An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)
• Antiproteinuric Effects of Liraglutide Treatment
• Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
• A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
• Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
• Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease
• Effect of the Aquaretic Tolvaptan on Nitric Oxide System
• The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)
• Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
• Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
• Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan
• Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function
• Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
• A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
• Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)
• Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
• Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
• Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
• Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
• Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy
• Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy
• Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease
• Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease
• Helping Olfaction and Nutrition On Renal Replacement
• Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
• Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation
• Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
• Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis
• Glargine Versus NPH in Patients With Chronic Kidney Disease
• Folic Acid for Prevention of Contrast Induced Nephropathy
• Colchicine for Diabetic Nephropathy Trial
• Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy
• Acid-Base Compensation in Chronic Kidney Disease
• Ides in Highly Sensitized Patients Awaiting Kidney Transplantation
• Optimising Renal Outcome in Myeloma Renal Failure
• Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease
• A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
• Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula
• Sympatholysis in Chronic Kidney Disease
• Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria
• Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease
• The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)
• Ticagrelor and Anti-inflammatory Effects
• Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis
• An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Diseas
• Genotype and Platelet Reactivity in Patients on Hemodialysis
• Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
• Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
• A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
• Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With Immunoglobulin A Nephropathy on Stable RAAS Blockade
• Acthar on Proteinuria in IgA Nephropathy Patients
• European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
• Preventing Sickle Cell Kidney Disease
• Effect of Paricalcitol Over Vessel Wall
• Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
• A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
• A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
• Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study
• A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria
• Rifaximin Therapy in Chronic Kidney Disease
• Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
• Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis
• Compare the Renal Protective Effects of Febuxostat and Benzbromarone
• Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
• A Phase 2 Extension of Study GCS-100-CS-4003
• Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout
• A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
• The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study
• A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
• Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism
• A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency
• Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium for the Calculation of GFR and Validity Compared to the Renal Clearance of Inulin
• Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease
• Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
• A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis
• Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
• Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
• Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
• Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002
• Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2
• Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
• Effect of LIXIsenatide on the Renal System
• Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
• Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
• KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
• Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
• An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice
• 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
• The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
• Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Metformin in Kidney Disease
• Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
• Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
• Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
• Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )
• Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis
• Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.
• Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis
• Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
• Efficacy and Safety of Losartan in Children With Ig A Nephropathy
• Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria
• Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
• Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy
• An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD
• Trial to Compare 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring Hemodialysis Catheter Function
• Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease
• Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
• Phophate Lowering Trial
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
• Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
• Effect of Sevelamer on P-cresol Levels in CKD
• Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
• Chinese Medicine on Deferring Dialysis Initiation
• Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease
• Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
• A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy
• ONSET and OFFSET of Ticagrelor in ESRD
• Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
• A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
• Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease
• Pyridorin in Diabetic Nephropathy
• A Phase 2 Extension Study of Study GCS-100-CS-4002
• Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
• A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis
• Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis
• Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy
• A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects
• The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
• C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
• The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
• A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
• Lanreotide In Polycystic Kidney Disease Study
• Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
• Effects of Somatostatin on Liver in ADPKD
• Effects of Somatostatin on ADPKD Heart
• Atrasentan Spermatogenesis and Testicular Function
• Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• High Dose Atorvastatin for Preventing Contrast-induced Nephropathy
• Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
• Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy
• Boceprevir in End Stage Renal Disease (ESRD)
• A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
• Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis
• Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)
• Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy
• Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)
• Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
• Aggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy
• Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
• Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
• BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration
• Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
• Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis
• BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy
• Comparison Among Erythropoietin Stimulating Agents
• Zibotentan Better Renal Scleroderma Outcome Study
• Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)
• Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
• PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
• Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria
• Metabolic Acidosis and Vascular Function in Patients With Chronic Kidney Disease
• Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules
• Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
• Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
• Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract
• Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease
• A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
• Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis
• Molecular MRI of the Fibrotic Heart
• Evaluating the Effect of Senna in Uremic Pruritus
• ACTH Treatment of APOL1- Associated Nephropathy
• Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition
• The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer
• Contrast Nephropathy and Nitrates
• Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)
• Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.
• A Study of LY2928057 in Hemodialysis Participants
• Losartan for Sickle Cell Kidney Disease
• Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
• A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
• ISCHEMIA-Chronic Kidney Disease Trial
• Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease
• A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
• Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia
• Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
• Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
• Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects
• Supplementation With Cholecalciferol in Dialysis Patients
• Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
• Sevelamer in Proteinuric CKD
• Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
• ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
• Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting
• Fosrenol Post-marketing Surveillance in Japan
• Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Diseas
• Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
• Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease
• Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
• An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis
• To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy
• Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
• A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin
• Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.
• Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
• Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
• 20-Week Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
• Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group
• Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
• Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
• A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)
• Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy
• Study of South African Dialysis Patients
• Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy
• A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
• Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis
• HALT Progression of Polycystic Kidney Disease Study B
• Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath
• PK of Serelaxin in Severe Renal Impairment and ESRD
• Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
• Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis
• Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction
• CSPPT- Chronic Kidney Diseases Study
• Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)
• Endovenous Versus Liposomal Iron in CKD
• Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
• Study Of Diabetic Nephropathy With Atrasentan
• Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia
• L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
• The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients
• The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
• A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
• Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
• A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
• MSC for Occlusive Disease of the Kidney
• Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease
• RAS Quantification in Patients With Aliskiren or Candesartan
• Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD
• Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients
• N-Acetyl Cystein and Contrast Nephropathy
• Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
• Safety and Tolerability Study of MCI-196
• Long-term Extension Study of MCI-196
• Dose-finding Study of MCI-196
• A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
• Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chroni
• Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease
• Kidney and Periodontal Disease Study
• Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
• Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
• Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease
• Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
• Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration
• Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
• Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis
• Renal Allograft Tolerance Through Mixed Chimerism
• Minocycline and Proteinuria in Diabetic Nephropathy
• Study of LY3016859 in Participants With Diabetic Nephropathy
• Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
• Paricalcitol Effect on Anemia in CKD
• Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
• Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
• The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease
• Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
• A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
• A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
• A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)
• Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease
• A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
• A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
• Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
• Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
• Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
• A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
• Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis
• The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
• Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension
• Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
• Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
• Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
• A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)
• Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy
• Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy
• Safety Study of GCS-100 to Treat Chronic Kidney Disease
• A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy
• Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.
• Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease
• Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
• Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
• FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
• A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on
• Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.
• Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
• Mineralocorticoid Receptor Antagonists in End Stage Renal Disease
• Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease
• A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
• Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.
• Sirolimus for Massive Polycystic Liver
• Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study)
• Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
• Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
• Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients
• Pasireotide LAR in Severe Polycystic Liver Disease
• Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
• Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
• A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects
• Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
• Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
• A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
• Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
• Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
• Using mTOR Inhibitors in the Prevention of BK Nephropathy
• Hyperglycemia in Renal Transplantation
• Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
• Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder
• Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease
• Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
• Study of Lanreotide to Treat Polycystic Kidney Disease
• N Acetyl Cysteine for Cystinosis Patients
• Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
• Study of FG-4592 in Subjects With Chronic Kidney Disease in China
• Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China
• Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
• Renal Denervation in Diabetic Nephropathy
• Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
• 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
• 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
• Fosrenol and Phosphorus Balance - Lanthanum Carbonate
• PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease
• A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
• HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)
• A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
• A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
• An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease
• Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.
• A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
• Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects
• Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor
• Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
• Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia
• Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN)
• Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
• Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)
• A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease
• A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
• Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Increased Renal Oxygenation and Angiotensin Converting Enzyme Inhibition
• The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
• Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease
• High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease
• Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
• Vitamin D Metabolism in Chronic Kidney Disease Patients
• PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia
• A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis
• Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients
• Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
• A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease
• Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
• Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis
• A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
• The Effects of Sevelamer Carbonate on Diabetic Nephropathy
• Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
• N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy
• A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
• Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment
• Losartan to Reverse Sickle Nephropathy
• Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
• Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
• Vitamin D Supplementation in Diabetic Nephropathy
• Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil
• Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy
• Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)
• A Multi-Center, Open-Label Study
• Prevention of Serious Adverse Events Following Angiography
• Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
• A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.
• A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
• Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
• Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
• Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)
• Alkali Therapy in Chronic Kidney Disease
• 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
• Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy
• Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients
• A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy
• Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction
• Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
• Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
• Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease
• A Study of LY2623091 in Male and Females With Chronic Kidney Disease
• Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
• Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
• Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan
• Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder
• A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
• Steroids and Azathioprine in Advanced IgAN
• Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent
• Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
• Vitamin D and Arterial Function in Patients With Chronic Kidney Disease
• A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
• 42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
• Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)
• Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients
• Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
• Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
• Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
• Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
• Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
• Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
• Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
• Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled D
• Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients
• Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
• Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
• BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease
• Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
• Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
• Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease
• Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging
• Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients
• A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
• Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy
• Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
• A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
• The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
• Measurement of Kidney Blood Flow and Oxygen Levels by MRI
• Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients
• Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease
• Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease
• A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
• Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients
• To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
• Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
• Effect of Adipokines in Hemodialysis Patients
• Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients
• Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
• Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
• A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]
• Pediatric Chronic Kidney Disease Safety and Efficacy
• Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4
• An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)
• Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
• N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
• Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
• Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose
• Atorvastatin and Sympathetic Activity in Chronic Kidney Disease
• An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
• A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy
• Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia
• Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients
• Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
• Study of FG-4592 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
• A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin
• Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance
• Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
• Safety and Efficacy Study for AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
• Bosutinib For Autosomal Dominant Polycystic Kidney Disease
• Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
• Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients
• Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients
• Uric Acid and the Endothelium in CKD
• Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
• Safety and Dose Finding Study of Xigris in Hemodialysis Patients
• Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial
• A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients
• Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
• A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D
• Impact of Vitamin D Therapies on Chronic Kidney Disease
• Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
• Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)
• Influence of Aliskiren on Proteinuria
• Tolvaptan Extension Study in Participants With ADPKD
• Impact of Vitamin D on Diabetic Kidney Disease in African Americans
• Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD
• The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
• Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD
• Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
• Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy
• The Effects of Atorvastatin on the Nitrogen Oxide-system in Patients With Type 2 Diabetes and Nephropathy
• Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease
• Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
• A Study in Participants With End-Stage Renal Disease
• A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)
• Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
• Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
• MEmbranous Nephropathy Trial Of Rituximab
• Impact of Vitamin D Repletion in Hemodialysis Patients
• Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
• Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
• A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.
• Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
• The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease
• The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
• Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid
• Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
• The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
• Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
• Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
• Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease
• Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis
• Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
• Polymorphism of Oxidative Stress Genes in the Pathogenesis and Antioxidant Prevention of Contrast Induced Nephropathy
• Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease
• Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
• Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
• Comparison of the Protective Effect of Desflurane and Propofol in Patients With Renal Transplantation
• Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy
• Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
• Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
• Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD
• MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5
• A Study in Participants With Diabetic Kidney Disease
• Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
• Study in Chronic Kidney Disease (CKD) Not on Dialysis
• The Effects of Bindarit in Diabetic Nephropathy
• Pilot Study of Velcade® in IgA Nephropathy
• Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
• A Safety Study of Pentoxifylline for the Treatment of Anemia
• Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients
• Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
• Trial to Optimize Mineral Outcomes in Dialysis Patients
• Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
• RenalGuard System and Contrast Media
• Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children
• Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
• Aliskiren in Patients With Idiopathic Membranous Nephropathy
• Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
• Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
• Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
• Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis
• A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
• Efficacy of Statins In Prevention of CIN
• Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease
• Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients
• Effects of PH3 in Diabetic Nephropathy
• Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery
• Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
• Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
• A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
• Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy
• Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
• A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
• Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease
• Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia
• A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
• Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
• The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
• Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
• hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
• Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
• A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
• Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)
• Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
• A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
• Effect of Turmeric on Diabetic Nephropathy
• Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
• Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
• Everolimus on CKD Progression in ADPKD Patients
• Colchicine for Diabetic Nephropathy
• Metabolic Effects of Paricalcitol
• Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy
• The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
• A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease
• The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease
• Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients
• FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease
• Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemo
• Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
• Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
• Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)
• The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure
• Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
• Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
• A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)
• Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
• Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
• Observational Prospective Study on Patients Treated With Norditropin®
• Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
• Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
• Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy
• Chronic Kidney Disease Antidepressant Sertraline Trial
• Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
• Evaluation of New Markers to Assess Kidney Function
• Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment
• Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
• Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease
• A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)
• A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
• Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade
• A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
• Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy
• Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo
• Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy
• Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy
• Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
• A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy
• VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.
• Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)
• Study of Vitamin D3 Supplementation in Patients With Chronic Kidney Disease
• Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria
• Sympathetic Nerve Activity in Renal Failure
• Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
• DIVINE: Dialysis Infection and Vitamin D In New England
• Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
• Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients
• Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
• Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function
• Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
• Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
• Vitamin D, Chronic Kidney Disease (CKD) and the Microcirculation
• Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults
• Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
• Aliskiren for Immunoglobulin A (IgA) Nephropathy
• Aldosterone in Diabetic Nephropathy
• Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
• Mycophenolate Mofetil for IgA Nephropathy
• Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
• Kremezin Study Against Renal Disease Progression in Korea
• Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
• The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria
• Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
• Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
• Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
• Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
• Niacin and Endothelial Function in Early CKD
• Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease
• Shiga Progression of Diabetes, Nephropathy and Retinopathy
• Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
• A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]
• Repeat Dose Safety Study for Compound to Treat Anemia
• Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)
• A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis
• N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
• A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
• Study of Phosphate Levels in Patients With Chronic Kidney Disease
• Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
• Sitaxsentan in Proteinuric Chronic Kidney Disease
• Calcineurin Free Immunosuppression in Renal Transplant Recipients
• Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
• Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects
• Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
• A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection
• Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
• Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease
• Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy
• 20070360 Incident Dialysis
• Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
• Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism
• Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients
• Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease
• A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
• Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
• Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes
• A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
• N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
• Adiponectin and Insulin Resistance in Diabetic Nephropathy
• A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Ery
• Vitamin D Repletion in Chronic Kidney Disease
• Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
• Statins for Prevention of Contrast Induced Nephropathy
• Hydration and Contrast-Induced Nephropathy in Primary Angioplasty
• Study of Atorvastatin Dose Dependent Reduction of Proteinuria
• The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
• Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study
• Phase 2 Study of FG-4592 in Subjects With Anemia and Chronic Kidney Disease Not Requiring Dialysis
• "Steroids and Azathioprine Versus Steroids Alone in IgAN"
• Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy
• Vitamin D and Coronary Calcification Study
• A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis
• Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN)
• Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
• Sevelamer Hydrochloride in Peritoneal Dialysis Patients
• Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
• Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
• Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
• Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy
• A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis
• The Effect of Folic Acid Administration in the Progression of Microalbuminuria
• The Acetylcysteine for Contrast-Induced Nephropathy Trial
• Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes
• Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange
• Endothelin Receptor Antagonism in Proteinuric Nephropathy
• Aliskiren and Muscle Sympathetic Nerve Activity
• A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.
• Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis
• Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection
• Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis
• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis
• Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention
• Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)
• Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection
• Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
• Evaluation of Renal Drug Transport in Healthy Volunteers
• Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
• Queen's University Investigation of Calcification in Chronic Kidney Disease
• An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis
• Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA
• 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
• A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients
• Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
• Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
• DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
• Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy
• Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy
• Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients
• Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
• Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
• A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
• Paricalcitol Injection Phase II Trial
• A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
• Testosterone Replacement Therapy in Advanced Chronic Kidney Disease
• A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
• A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease
• Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
• Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy
• Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.
• A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis
• Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function
• Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
• Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)
• Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis
• Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
• Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
• Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients
• Paricalcitol for the Treatment of Immunoglobulin A Nephropathy
• Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease
• Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function
• African American Study of Kidney Disease and Hypertension ABPM Pilot Study
• A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
• A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
• Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
• Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
• ARIA (Atacand Renoprotection In NephropAthy Pt.)
• Optimalization of Nephroprotection Using N-Acetylcysteine
• Optimalization of Nephroprotection Using Atorvastatin (Sortis)
• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
• Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
• Benfotiamine in Diabetic Nephropathy
• A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
• Adiponectin in Obese Women With T2DN and Effects by RAS Blocker
• Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
• A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
• Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
• Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
• VA NEPHRON-D: Diabetes iN Nephropathy Study
• Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
• Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
• Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
• Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
• A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
• Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
• Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate
• A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients
• Nephropathy In Type 2 Diabetes and Cardio-renal Events
• Vitamin D 2 to Dialysis Patients
• Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
• Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
• NESP Pediatric Study
• Effects of Mesna on Homocysteine in Kidney Failure
• To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)
• To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
• Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)
• Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
• Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease
• A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
• Safe Renal Function In Long Term Heart Transplanted Patients
• A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis
• A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
• Vitamin D and Carboxy PTH Fragments in Coronary Calcification
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
• Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
• Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
• The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
• Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
• COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT
• The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
• A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.
• The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy
• Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy
• Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)
• Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
• Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
• Follow-up Study to Previous CARE Trial
• Loop Diuretics in Chronic Kidney Disease
• Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
• Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
• A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease
• Treatment of Secondary Hyperparathyroidism in the Uremic Patient
• Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
• Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy
• Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.
• Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
• Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate
• Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
• Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)
• Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
• Rosiglitazone and Insulin Resistance in Renally Impaired Patients
• A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
• Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
• Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion
• A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
• A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
• Head to Head Study Against Sevelamer Hydrochloride
• Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate
• An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
• Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
• A Study of NeoRecormon in Patients With Chronic Kidney Disease.
• Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis
• Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
• Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis
• The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients
• A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)
• Inhibition of Aldosterone in Patients With Chronic Renal Disease
• Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
• Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
• A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
• Rituximab in Membranous Nephropathy
• Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
• A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
• A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
• The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
• Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
• Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus
• A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
• Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
• Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
• Oxidative Stress and Hemodialysis Access Failure
• Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
• Rituximab in the Treatment of Idiopathic Membranous Nephropathy
• Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
• Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn
• Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
• Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease
• Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients
• Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
• Bicarbonate v Saline to Prevent Contrast Nephropathy
• Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease
• Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study
• A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
• Improving Outcomes in Patients With Kidney Disease Due to Diabetes
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD
• STAAR-1 Clinical Study
• STAAR-3 Clinical Study
• Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
• STAAR-2 Clinical Study
• Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease
• Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
• MMF After Pediatric Liver Transplantation
• Pioglitazone and Losartan Provides Additional Renoprotection
• Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease
• STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients
• Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)
• Olmesartan Medoxomil and Diabetic Nephropathy
• Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
• Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy
• Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
• Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide
• Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
• Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
• Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
• Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis
• Renoprotection in Early Diabetic Nephropathy in Pima Indians
• A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)
• A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
• Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)
• Spironolactone Safety in Dialysis Patients
• Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
• Dialysis Clinical Outcomes Revisited (DCOR) Trial
• Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing
• Effect of Pyridorin in Patients With Diabetic Nephropathy
• Effect of Pyridorin in Patients With Diabetic Nephropathy
• Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy
• Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
• Spironolactone in Diabetic Nephropathy
• Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
• VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
• Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
• Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease
• Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage
• Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy
• Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
• Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
• Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study
• Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)
• Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
• A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)
• A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)
• Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
• Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
• Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
• YSPSL for Prevention of Delayed Graft Function Part B
• Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
• Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
• Patients With Renal Impairment Undergoing CT
• Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
• Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)
• Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)
• Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
• Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients
• HALT Progression of Polycystic Kidney Disease Study A
• Study Evaluating Sirolimus in the Treatment of Kidney Transplant
• NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels
• Effects of Atorvastatin Versus Probucol on Small Dense LDL
• The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
• A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids
• The Use of Cilostazol in Patients With Diabetic Nephropathy
• Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
• Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
• Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis
• Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients
• Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
• A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
• Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
• Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus
• Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation
• The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
• CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation
• Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
• Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
• Safety and Efficacy of Iron Sucrose in Children
• Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
• Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
• Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction
• Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
• Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
• Peginesatide for Anemia in Chronic Hemodialysis Patients
• Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
• Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
• High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
• A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.
• A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
• EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
• A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
• Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.
• Intravenous Iron in Patients With Anemia of Chronic Kidney Disease
• Iron Sucrose in Stage 3/4 Kidney Disease
• Statins in Proteinuric Nephropathies
• Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
• Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
• Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
• A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
• Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant
• Olmesartan Medoxomil in Diabetes Mellitus
• Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.
• Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
• Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
• Prevention of Contrast-Induced Nephropathy
• Active Vitamin D Effect on Left Ventricular Hypertrophy
• Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
• Antialbuminuric Effects of Valsartan and Lisinopril
• Antiproteinuric Effect of Valsartan and Lisinopril
• Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
• Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids
• Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease
• A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Ove
• Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
• Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension
• Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
• Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
• Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy
• Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)
• EPO Deep Tank in Dialysis Subjects
• Efficacy of Pentoxifylline on Chronic Kidney Disease
• INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy
• 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
• Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis
• Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
• Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood
• Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis
• Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
• Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation
• Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)
• Cidofovir in Renal Transplant Recipients With BKVN
• Nitric Oxide (NO) Activity and Diabetic Nephropathy
• Mycophenolate Mofetil in Membranous Nephropathy
• Treatment of Patients With Idiopathic Membranous Nephropathy
• START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
• Effect of Sulodexide in Overt Diabetic Nephropathy
• Effect of Sulodexide in Early Diabetic Nephropathy
• Study of Heart and Renal Protection
• An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)
• Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
• Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease
• To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy
• Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006
• Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
• Study to Evaluate Effectiveness of Aranesp®
• Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis
• Aranesp® Monthly Preference Study - 2
• SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
• Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis
• Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
• Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
• Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis
• Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis
• Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
• A Research Study for Patients With End-Stage Renal Disease (ESRD)
• Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
• Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
• Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy
• Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria
• Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
• Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
• Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
• Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
• Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)
• Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
• Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
• Study of LJP 394 in Lupus Patients With History of Renal Disease
• Optimal Treatment for Kidney Disease in HIV Infected Adults
• A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
• Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
• Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
• Angiotensin II Blockade for Chronic Allograft Nephropathy
• HALT Progression of Polycystic Kidney Disease Study B
• Soy Protein in Early Diabetic Nephropathy
• Steroid Treatment for Kidney Disease
• Treatment of Diabetic Nephropathy
• Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
• Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
• Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes
• Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
• Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
• Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
• Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
• Homocysteine Study (HOST)
• Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
• Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
• Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis
• Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
• A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease
• Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys
• Oxaliplatin in Cancer Patients With Impaired Kidney Function
• A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction
• A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)
• A Study of Zidovudine in HIV-Infected Patients With Kidney Problems